Back to Variant Registry
AllergiesasthmaEvidence 3
rs6924808 · MMS22L
Risk-Allele Phenotype
MMS22L rs6924808 — associated with Response to inhaled glucocorticoid treatment in asthma (change in FEV1) based on genetic association studies.
Reference-Allele Phenotype
Normal MMS22L function at this locus, with no elevated genetic risk contribution to Response to inhaled glucocorticoid treatment in asthma (change in FEV1) from this variant.
Evidence Level
3 — Limited — single study or in-vitro See methodology for how we grade evidence.
Cross-References
Informational only
This page summarizes population-level evidence about a genetic variant. It is not a diagnosis. Your individual risk depends on your full genome, lifestyle, environment, and family history. Consult a healthcare provider for personalized medical advice.
Want to know your status at rs6924808?
Upload your DNA file — Atlagene checks this variant and 700+ others across 21 health categories.
Get Started Free